- pre-existing diabetes mellitus at the time of admission <br/ >- in those without diagnosed diabetes at baseline, a fasting or random blood glucose level > 200 mg/ dl at any time point during admission <br/ >- patients who have received â?¥6 mg/day of Dexamethasone or â?¥30mg/day of methylprednisolone <br/ >- patients receiving immunomodulators for at least 24 hours <br/ >- patients receiving systemic anti-bacterial drugs <br/ >- patients with hematologic malignancies <br/ >- receiving bone marrow transplant/ systemic chemotherapy/ HIV-AIDS/ immunosuppressive therapy after organ transplant <br/ >

- pre-existing diabetes mellitus at the time of admission <br/ >- in those without diagnosed diabetes at baseline, a fasting or random blood glucose level > 200 mg/ dl at any time point during admission <br/ >- patients who have received â?¥6 mg/day of Dexamethasone or â?¥30mg/day of methylprednisolone <br/ >- patients receiving immunomodulators for at least 24 hours <br/ >- patients receiving systemic anti-bacterial drugs <br/ >- patients with hematologic malignancies <br/ >- receiving bone marrow transplant/ systemic chemotherapy/ HIV-AIDS/ immunosuppressive therapy after organ transplant <br/ >

- pre-existing diabetes mellitus at the time of admission <br/ >- in those without diagnosed diabetes at baseline, a fasting or random blood glucose level > 200 mg/ dl at any time point during admission <br/ >- patients who have received â?¥6 mg/day of Dexamethasone or â?¥30mg/day of methylprednisolone <br/ >- patients receiving immunomodulators for at least 24 hours <br/ >- patients receiving systemic anti-bacterial drugs <br/ >- patients with hematologic malignancies <br/ >- receiving bone marrow transplant/ systemic chemotherapy/ HIV-AIDS/ immunosuppressive therapy after organ transplant <br/ >

- pre-existing diabetes mellitus at the time of admission <br/ >- in those without diagnosed diabetes at baseline, a fasting or random blood glucose level > 200 mg/ dl at any time point during admission <br/ >- patients who have received â?¥6 mg/day of Dexamethasone or â?¥30mg/day of methylprednisolone <br/ >- patients receiving immunomodulators for at least 24 hours <br/ >- patients receiving systemic anti-bacterial drugs <br/ >- patients with hematologic malignancies <br/ >- receiving bone marrow transplant/ systemic chemotherapy/ HIV-AIDS/ immunosuppressive therapy after organ transplant <br/ >